Data Collection for Medicare Beneficiaries Receiving Implantable Cardioverter-defibrillators for Primary Prevention of Sudden Cardiac Death

ICR 201308-0938-018

OMB: 0938-0967

Federal Form Document

Forms and Documents
ICR Details
0938-0967 201308-0938-018
Historical Active 200811-0938-005
HHS/CMS 20315
Data Collection for Medicare Beneficiaries Receiving Implantable Cardioverter-defibrillators for Primary Prevention of Sudden Cardiac Death
Reinstatement with change of a previously approved collection   No
Regular
Approved without change 09/20/2013
Retrieve Notice of Action (NOA) 08/15/2013
  Inventory as of this Action Requested Previously Approved
09/30/2016 36 Months From Approved
20,424 0 0
139,656 0 0
0 0 0

To encourage responsible and appropriate use of ICDs, CMS issued a Decision Memo for Implantable Defibrillators on January 27, 2005, indicating that ICDs will be covered for primary prevention of sudden cardiac death if the beneficiary is enrolled in either an FDA-approved category B IDE clinical trial (42 DFR ?405.201), a trial under the CMS Clinical Trial Policy (NCD Manual ?310.1) or a qualifying prospective data collection system (either a practical clinical trial or prospective systematic data collection, which is sometimes referred to as a registry).

US Code: 42 USC 1395y Name of Law: Exclusions from Coverage and Medicare as a Secondary Payer
  
None

Not associated with rulemaking

  78 FR 23768 04/22/2013
78 FR 44569 07/24/2013
No

  Total Approved Previously Approved Change Due to New Statute Change Due to Agency Discretion Change Due to Adjustment in Estimate Change Due to Potential Violation of the PRA
Annual Number of Responses 20,424 0 0 -29,576 0 50,000
Annual Time Burden (Hours) 139,656 0 0 127,156 0 12,500
Annual Cost Burden (Dollars) 0 0 0 0 0 0
Yes
Miscellaneous Actions
Yes
Changing Forms
The data collection form has changed significantly to delete data elements and fields that were found to be no longer applicable. While some additional data elements were added due to the collection of important information regarding device lead placement, many fields also were greatly improved by better field descriptors and definitions. The majority of the increased time necessary to complete the data form is due to the additional data elements related to device lead placement.

$0
No
No
No
No
No
Uncollected
Kayla Williams 410 786-5887 [email protected]

  No

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).
The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:
 
 
 
 
 
 
 
    (i) Why the information is being collected;
    (ii) Use of information;
    (iii) Burden estimate;
    (iv) Nature of response (voluntary, required for a benefit, or mandatory);
    (v) Nature and extent of confidentiality; and
    (vi) Need to display currently valid OMB control number;
 
 
 
If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.
08/15/2013


© 2024 OMB.report | Privacy Policy